HEALTH MANAGEMENT ASSOCIATES INC
10-Q, 1999-02-11
GENERAL MEDICAL & SURGICAL HOSPITALS, NEC
Previous: IFX CORP, 10-Q, 1999-02-11
Next: INTERLEAF INC /MA/, SC 13G/A, 1999-02-11



<PAGE>
 
                                  UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION

                             Washington, D.C. 20549

                                    FORM 10-Q

              [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d)
                     OF THE SECURITIES EXCHANGE ACT OF 1934

                For the Quarterly Period Ended December 31, 1998

                                       OR

              [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d)
                     OF THE SECURITIES EXCHANGE ACT OF 1934

                       For the transaction period from     to
                                                      ----   ----

                        Commission File Number 000-18799
                                              -----------

                       HEALTH MANAGEMENT ASSOCIATES, INC.
- --------------------------------------------------------------------------------
             (Exact name of Registrant as specified in its charter)


          DELAWARE                                         61-0963645          
- ---------------------------------                     --------------------------
(State or other jurisdiction                            (I.R.S. Employer
of incorporation or organization)                     Identification Number)

 5811 Pelican Bay Boulevard, Suite 500, Naples, Florida         34108-2710  
- -------------------------------------------------------        -----------------
     (Address of principal executive offices)                   (Zip Code)



                                 (941)598-3131                    
               ----------------------------------------------------
               (Registrant's telephone number, including area code)

Indicate by check mark whether the Registrant (1) has filed all reports required
to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during
the preceding 12 months, and (2) has been subject to such filing requirements
for the past 90 days.

                                                                Yes  X   No    
                                                                    ----   ----

At February 1, 1999, the following shares of the Registrant were outstanding:


       Class A Common Stock                           251,875,849 shares
<PAGE>
 
                       HEALTH MANAGEMENT ASSOCIATES, INC.
                                    FORM 10-Q
                FOR THE QUARTERLY PERIOD ENDED DECEMBER 31, 1998


                                      INDEX
                                      -----

<TABLE>
<CAPTION>

PART I.  FINANCIAL INFORMATION                                                 Page
                                                                             
Item 1.  Financial Statements
<S>     <C>                                                                  <C> 
         Consolidated Statements of Income --
           Three Months Ended December 31, 1998 and 1997.................     3
                                                                           
         Condensed Consolidated Balance Sheets--                           
           December 31, 1998 and September 30, 1998......................     4
                                                                           
         Condensed Consolidated Statements of Cash Flows--                 
           Three Months Ended December 31, 1998 and 1997.................     5
                                                                           
         Notes to Interim Condensed Consolidated Financial Statements....     6
                                                                           
Item 2.  Management's Discussion and Analysis of Financial                 
                  Condition and Results of Operations....................    7-10
                                                                           
PART II.          OTHER INFORMATION......................................     11
                                                                           
Signatures...............................................................     12
                                                                           
Index To Exhibits........................................................     13  

</TABLE>

 

                                       2
<PAGE>
 
PART I.  FINANCIAL INFORMATION
Item 1.  Financial Statements


                       HEALTH MANAGEMENT ASSOCIATES, INC.

                        CONSOLIDATED STATEMENTS OF INCOME
                    (In thousands, except per share amounts)
                                   (Unaudited)

<TABLE>
<CAPTION>

                                                               Three months ended
                                                                   December 31,
                                                            --------------------------
                                                              1998             1997
                                                            --------         ---------
<S>                                                         <C>               <C>
Net patient service revenue .............................   $305,496          $234,570

Costs and expenses:
   Salaries and benefits.................................    113,643            84,567
   Supplies and expenses.................................     88,361            71,080
   Provision for doubtful accounts.......................     29,095            21,972
   Depreciation and amortization.........................     14,507            10,172
   Rent expense..........................................      7,577             5,461
   Interest, net.........................................      1,360               433
                                                            --------          --------
       Total costs and expenses .........................    254,543           193,685
                                                            --------          --------

Income before income taxes...............................     50,953            40,885

Provision for income taxes ..............................     19,998            16,048
                                                            --------          --------

Net income ..............................................   $ 30,955          $ 24,837
                                                            ========          ========

Net income per share:
    Basic................................................   $    .12          $    .10
                                                            ========          ========
    Diluted..............................................   $    .12          $    .10
                                                            ========          ========

Weighted average number of
 shares outstanding:
    Basic................................................    251,653           244,829
                                                            ========          ========
    Diluted..............................................    258,114           251,135
                                                            ========          ========
</TABLE>


                             See accompanying notes.
                                        3
<PAGE>
 
                      HEALTH MANAGEMENT ASSOCIATES, INC.

                     CONDENSED CONSOLIDATED BALANCE SHEETS
                                (In thousands)

                                    ASSETS
                                    ------

<TABLE>
<CAPTION>
                                                                   December 31,     September 30,  
                                                                      1998              1998       
                                                                  -------------    -------------- 
                                                                   (Unaudited)    
<S>                                                             <C>               <C> 
Current assets:
  Cash and cash equivalents ...............................        $     8,574        $    12,685
  Receivables--net ........................................            253,282            243,542
  Supplies, prepaids and other assets .....................             35,934             32,983
  Funds held by trustee ...................................              1,753              1,458
  Income taxes - deferred .................................             18,039             18,039
       Total current assets ...............................            317,582            308,707
                                                                   -----------         ----------

Property, plant and equipment .............................            980,544            925,956
  Less accumulated depreciation and amortization ..........            201,428            188,201
                                                                   -----------         ----------
       Net property, plant and equipment ..................            779,116            737,755
                                                                                  
Funds held by trustee .....................................              4,110              3,932
Excess of cost over acquired assets, net ..................             45,737             46,674
Deferred charges and other assets .........................             14,855             15,037
                                                                   -----------         ----------
                                                                                  
                                                                   $ 1,161,400        $ 1,112,105
                                                                   ===========        ===========
<CAPTION> 

                      LIABILITIES AND STOCKHOLDERS' EQUITY                            
                      ------------------------------------                            
<S>                                                             <C>               <C> 
Current liabilities:                                                              
Accounts payable ..........................................        $    49,815        $    44,300
  Accrued expenses and other liabilities ..................             43,792             42,672
  Due to third party programs .............................             14,844             14,844
  Current maturities of long-term debt ....................              6,889              8,544
  Income taxes--currently payable and deferred ............             27,832             10,186
                                                                   -----------         ----------
       Total current liabilities ..........................            143,172            120,546

Deferred income taxes .....................................             39,603             39,603
Other long-term liabilities ...............................             17,116             17,878
Long-term debt ............................................            138,320            134,217
Obligation under put option contracts .....................                  -             43,036
                                                                                  
Stockholders' equity:                                                             
  Preferred stock, $.01 par value, 5,000,000                                      
    shares authorized .....................................                  -                  -
  Common stock, Class A, $.01 par value, 300,000,000                              
    shares authorized, 251,871,000 and 251,558,000                                
    shares issued and outstanding at December 31,                                 
    1998 and September 30, 1998, respectively .............              2,519              2,491
  Additional paid-in capital ..............................            285,159            241,677
  Retained earnings .......................................            543,612            512,657
                                                                   -----------         ----------
                                                                       831,290            756,825
  Less treasury stock, 499,000 shares at cost .............             (8,101)                 -
                                                                   -----------         ----------
       Total stockholders' equity .........................            823,189            756,825
                                                                   -----------         ----------
                                                                   $ 1,161,400        $ 1,112,105
                                                                   ===========        ===========
</TABLE> 

                             See accompanying notes.
                                        4

<PAGE>
 
                      HEALTH MANAGEMENT ASSOCIATES, INC.                       

                 CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
                                 (In thousands)
                                   (Unaudited)

<TABLE> 
<CAPTION> 
                                                                    Three months ended
                                                                       December 31,     
                                                                   --------------------
                                                                    1998         1997  
                                                                   -------      -------
<S>                                                              <C>         <C> 
Cash flows from operating activities:
  Net income ..................................................... $ 30,955    $ 24,837
  Adjustments to reconcile net income to net
   cash provided by operating activities:
     Depreciation and amortization ...............................   14,507      10,172
     Loss/(gain) on sale of fixed assets .........................       70         (56)

     Changes in assets and liabilities:
       Receivables--net ..........................................  (11,829)    (10,464)
       Supplies and other current assets .........................   (2,884)     (2,920)
       Long-term assets ..........................................       (4)        969
       Accounts payable ..........................................    5,515         529
       Accrued expenses and other liabilities ....................    1,011         199
       Income taxes--
         currently payable and deferred ..........................   17,646      14,157
       Other long term liabilities ...............................     (762)     (2,897)
                                                                   --------    --------

          Net cash provided by
            operating activities .................................   54,225      34,526
                                                                   --------    --------
Cash flows from investing activities:
  Acquisition of facilities, net of cash acquired ................   (7,021)    (20,232)
  Additions to property, plant and equipment .....................  (38,000)    (10,740)
  Proceeds from sale of equipment ................................        1         128
                                                                   --------    --------

          Net cash used in investing activities ..................  (45,020)    (30,844)
                                                                   --------    --------
Cash flows from financing activities:
  Proceeds from long-term borrowings .............................      133         136
  Principal payments on debt .....................................   (7,761)     (2,459)
  Proceeds from issuance of common stock .........................    2,564       4,278
  Purchase of treasury stock .....................................   (8,101)          -
  (Increase)/decrease in funds held by trustee ...................     (151)       (631)
                                                                   --------    --------
          Net cash (used in) provided by
            financing activities .................................  (13,316)      1,324
                                                                   --------    --------
                Net (decrease)increase in cash
                  and cash equivalents ...........................   (4,111)      5,006

Cash and cash equivalents at beginning of period .................   12,685      67,381
                                                                   --------    --------

Cash and cash equivalents at end of period ....................... $  8,574    $ 72,387
                                                                   ========    ========
</TABLE> 

                             See accompanying notes.
                                        5
<PAGE>
 
                      HEALTH MANAGEMENT ASSOCIATES, INC.

          NOTES TO INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

1.  Basis of Presentation
- -------------------------

         The condensed consolidated balance sheet as of September 30, 1998 has
been derived from the audited consolidated financial statements included in
Health Management Associates, Inc.'s (the Company's) 1998 Annual Report. The
interim consolidated financial statements at December 31, 1998 and for the three
months ended December 31, 1998 and 1997 are unaudited; however, such interim
statements reflect all adjustments (consisting only of a normal recurring
nature) which are, in the opinion of management, necessary for a fair
presentation of the financial position and results of operations for the interim
periods presented. The results of operations for the interim periods presented
are not necessarily indicative of the results to be expected for the full year.
The interim financial statements should be read in conjunction with the audited
consolidated financial statements of the Company included in its 1998 Annual
Report.

2.  Earnings Per Share
- ----------------------

         The following table sets forth the computation of basic and diluted
earnings per share (in thousands, except per share amounts):



                                                          December 31, 
                                                       1998          1997
                                                      -------       -------
     Numerator: 
          Net income                                  $30,955       $24,837
                                                      =======       =======
     Denominator:
       Denominator for basic earnings
          per share-weighted average shares           251,653       244,829
       Effect of dilutive securities-
          Employee stock options                        6,461         6,306
                                                      -------       -------

       Denominator for diluted earnings
          per share                                   258,114       251,135
                                                      =======       =======
     Basic earnings per share                         $   .12       $   .10
                                                      =======       ======= 
     Diluted earnings per share                       $   .12       $   .10
                                                      =======       =======

         During October 1998 the Company purchased 498,700 shares of its own
common stock on the open market for a total cost of $8,101,000.
                                    

                                       6
<PAGE>
 
Item 2.  Management's Discussion and Analysis of Financial
         Condition and Results of Operations

         Results of Operations
         ---------------------
         Three months ended December 31, 1998 compared
         ---------------------------------------------
         to three months ended December 31, 1997
         ---------------------------------------

             Net patient service revenue for the three months ended December 31,
         1998 ("1998 Period") was $305,496,000, as compared to $234,570,000 for
         the three months ended December 31, 1997 ("1997 Period"). This
         represented an increase in net patient service revenue of $70,926,000,
         or 30.2%. Hospitals in operation for the entire 1998 Period and 1997
         Period ("same hospitals") provided $14,286,000 of the increase in net
         patient service revenue, which resulted primarily from inpatient and
         outpatient volume increases. The remaining increase of $56,640,000
         included $56,731,000 of net patient service revenue from the
         acquisition of the 125-bed Southwest Hospital effective November 1,
         1997, the 221-bed River Oaks Health System effective January 1, 1998,
         the 180-bed Riley Memorial Hospital effective January 2, 1998 and the
         Regional Healthcare Inc., health system effective June 1, 1998, offset
         by a decrease of $91,000 in Corporate and miscellaneous revenue.

             During the 1998 Period the Company's hospitals generated patient
         days of service and an occupancy rate of 161,915 and 46.1%,
         respectively, versus 132,922 and 45.3%, respectively, for the 1997
         Period. Same hospital patient days and occupancy rates were 132,801 and
         46.1%, respectively, for the 1998 Period, and 130,897 and 45.8%,
         respectively, for the 1997 Period. Same hospital admissions for the
         Company during the 1998 Period were 26,831, up 2.2% from the 26,264
         admissions during the 1997 Period.

             The Company's operating expenses (salaries and benefits, supplies
         and expenses, provision for doubtful accounts and rent expense) for the
         1998 Period were $238,676,000 or 78.1% of net patient service revenue
         as compared to $183,080,000 or 78.0% of net patient service revenue for
         the 1997 Period. Of the total $55,596,000 increase, approximately
         $12,254,000 related to same hospitals, which was largely attributable
         to increased patient volumes. Another $42,762,000 of increased
         operating expense related to the acquisitions mentioned previously. The
         remaining $580,000 represented an increase in Corporate and
         miscellaneous other operating expenses.

             The Company's depreciation and amortization costs increased by
         $4,335,000 and interest expense increased by $927,000. The increase in
         depreciation and amortization resulted primarily from the acquisitions
         mentioned previously. The increase in interest expense resulted from
         acquisition related debt, as well as a decrease in investment income in
         the 1998 Period, which is netted against interest expense.

                                       7
<PAGE>
 
Item 2.  Management's Discussion and Analysis of Financial
         Condition and Results of Operations
 
            The Company's income before income taxes was $50,953,000 for the
         1998 Period as compared to $40,885,000 for the 1997 Period, an increase
         of $10,068,000, or 24.6%. The increase resulted primarily from same
         hospital volume increases and the acquisitions mentioned previously.
         The Company's provision for income taxes was $19,998,000 for the 1998
         Period, as compared to $16,048,000 for the 1997 Period. These
         provisions reflect effective income tax rates of 39.25% for both
         periods. As a result of the foregoing, the Company's net income was
         $30,955,000 for the 1998 Period as compared to $24,837,000 for the 1997
         Period.

         Liquidity and Capital Resources
         -------------------------------

            The Company's operating cash flows totalled $54,225,000 for the 1998
         Period as compared to $34,526,000 for the 1997 Period. The positive
         cash flows resulted from the Company's improved profitability and
         management of its working capital. The Company's investing activities
         used $45,020,000 and $30,844,000 for the 1998 Period and 1997 Period,
         respectively. Construction costs related to the replacement of three
         existing hospitals accounted for the majority of the 1998 Period
         expenditures. Financing activities used net cash of $13,317,000 for the
         1998 Period and provided net cash of $1,324,000 for the 1997 Period.
         Increased principal debt reductions and purchases of the Company's
         common stock accounted for the majority of the change from the 1997
         Period to the 1998 Period. See the Condensed Consolidated Statements of
         Cash Flows for the three months ended December 31, 1998 and 1997 at
         page 5 of this Report.

            The Company's credit agreements contain certain covenants which,
         without prior consent of the banks, limit certain activities of the
         Company and its subsidiaries, including those relating to merger,
         consolidation and the Company's ability to secure indebtedness, make
         guarantees, and grant security interests. The Company must also
         maintain minimum levels of consolidated tangible net worth, debt
         service coverage and liabilities to net worth.

            At the present time, the Company anticipates that cash on hand,
         internally generated funds and funds available under its lines of
         credit will be sufficient to satisfy the Company's requirements for
         capital expenditures, future acquisitions and working capital in Fiscal
         1999.

         Year 2000 Computer Issues
         -------------------------

            The Year 2000 Computer Issue is the result of most computer programs
         using two digits rather than four to identify a year in a data field.
         These programs were designed and developed without considering

                                       8
<PAGE>
 
Item 2. Management's Discussion and Analysis of Financial
        Condition and Results of Operations (Continued)

        the impact of the upcoming change in the century. If not corrected, many
        computer applications could fail or create erroneous results on or after
        January 1, 2000.

            The Company has implemented a plan to evaluate and correct the
        effect of this problem on the Company's computer system and programs. As
        part of the plan, the Company is also contacting its principal vendors
        and suppliers to identify and correct the potential effects of this
        problem relating to embedded systems of certain computer aided medical
        and other equipment. In addition, the Company is contacting the Federal
        and State governments, other payors and other companies with which the
        Company's systems interface or on which they rely to monitor their
        timely completion of necessary upgrades.

            The company's financial systems, including general ledger, accounts
        payable, cash management and payroll already are substantially Year 2000
        compliant. Changes to the Company's patient accounting systems are
        underway. Facility testing of systems-wide changes is expected to be
        completed by the quarter ending March 31, 1999, with Company-wide
        implementation to be completed by the quarter ending June 30, 1999.

            The Company is utilizing both internal and external resources to
        complete the Year 2000 modifications. The majority of the costs relating
        to the Year 2000 Issue will be expensed as incurred. Management of the
        Company does not believe such costs will have a material adverse impact
        to the Company's future results of operation. However, there can be no
        guarantee that actual results could differ materially from those
        anticipated. Factors that might cause material differences include, but
        are not limited to, the availability of trained personnel and the
        ability to locate and correct all relevant computer coding and all
        medical equipment affected.

            As noted above, the Company is contacting its principal suppliers,
        other vendors and payors, including Federal and State governments,
        Medicare fiscal intermediaries, insurance companies and managed care
        companies, concerning the status of their Year 2000 compliance. The
        Company is not aware at this time whether those other systems are or
        will be Year 2000 compliant and is unable to estimate at this time the
        impact on the Company if one or more of those systems is not Year 2000
        compliant. For the foregoing reasons, the Company is not able to
        determine at this time whether the Year 2000 Computer Issue will
        materially affect its future financial results or financial condition.

                                       9
<PAGE>
 
tem 2.  Management's Discussion and Analysis of Financial
        Condition and Results of Operations (Continued)


        Forward-Looking Statements
        --------------------------

                Certain statements contained in this Form 10-Q, including,
        without limitation, statements containing the words "believes,"
        "anticipates," "intends," "expects" and words of similar import,
        constitute "forward-looking statements" within the meaning of the
        Private Securities Litigation Reform Act of 1995. Such forward-looking
        statements involve known and unknown risks, uncertainties and other
        factors that may cause the actual results, performance or achievements
        of the Company or industry results to be materially different from any
        future results, performance or achievements expressed or implied by such
        forward-looking statements. Such factors include, among others, the
        following: general economic and business conditions, both nationally and
        in the regions in which the Company operates; industry capacity;
        demographic changes; existing governmental regulations and changes in,
        or the failure to comply with, governmental regulations; legislative
        proposals for health care reform; the ability to enter into managed care
        provider arrangements on acceptable terms; changes in Medicare and
        Medicaid payment levels; liability and other claims asserted against the
        Company; competition; the loss of any significant ability to attract and
        retain qualified personnel, including physicians; the availability and
        terms of capital to fund additional acquisitions or replacement
        facilities. Given these uncertainties, prospective investors are
        cautioned not to place undue reliance on such forward-looking
        statements. The Company disclaims any obligation to update any such
        factors or to publicly announce the results of any revision to any of
        the forward-looking statements contained herein to reflect future events
        or developments.
 

                                       10
<PAGE>
 
                           PART II - OTHER INFORMATION


Item 1.  Legal Proceedings.
         -----------------

         None.

Item 2.  Changes in Securities.
         ----------------------

         None.

Item 3.  Defaults upon Senior Securities.
         --------------------------------

         None

Item 4.  Submission of Matters to a Vote of Security Holders
         ---------------------------------------------------

         None

Item 5.  Other Information.
         ------------------

         None

Item 6.  Exhibits and Reports on Form 8-K.
         ---------------------------------

         a.  Exhibits:
             --------

             See Index to Exhibits located on page 13.


         b.  Reports on Form 8-K:
             -------------------

             None

                                       11
<PAGE>
 
                                   SIGNATURES


         Pursuant to the requirements of the Securities Exchange Act of 1934,
the Registrant has duly caused this Report to be signed on its behalf by the
undersigned, thereunto duly authorized.




                                         HEALTH MANAGEMENT ASSOCIATES, INC.




DATE:  February 9, 1999                 BY:   /s/ Stephen M. Ray             
                                              ------------------------------
                                              Stephen M. Ray
                                              Senior Vice President-Finance
                                              (Duly authorized officer and
                                              Principal Financial Officer)

                                       12
<PAGE>
 
                               INDEX TO EXHIBITS


(2)      Plan of acquisition, reorganization, arrangement, liquidation or
         succession.

         Not applicable.

(3)      (i)      Articles of Incorporation
         3.1      The Fifth Restated Certificate of Incorporation, previously
                  filed and included as Exhibit 3.1 to the Company's Quarterly
                  Report on Form 10-Q for the quarter ended March 31, 1995, is
                  incorporated herein by reference.

         3.2      Cettificate of Amendment to Fifth Restated Certificate of
                  Incorporation, previously filed and included as Exhibit 4.5 to
                  the Company's Annual Report on Form 10-K for the year ended
                  September 30, 1998, is incorporated herein by reference.

         (ii)     By-laws
                  The By-laws, as amended, previously filed and included as
                  Exhibit 3.2 to the Company's Quarterly Report on Form 10-Q for
                  the quarter ended December 31, 1995, is incorporated herein by
                  reference.

(4)      Instruments defining the rights of security holders, including
         Indentures.

         The Exhibits referenced under (3) of this Index to Exhibits are
         incorporated herein by reference.

         Fourth Amended and Restated Credit and Reimbursement Agreement among
         the Company and NationsBank of Florida National Association and the
         Banks named therein, dated December 1, 1994, previously filed and
         included as Exhibit 4.12 to the Company's Annual Report on Form 10-K
         for the year ended September 30, 1994, is incorporated herein by
         reference.

         Credit Agreement dated May 6, 1996 between First Union National Bank of
         Florida and the Company, pertaining to a $10 million working capital
         and cash management line of credit, previously filed and included as
         Exhibit 4.3 to the Company's Annual Report on Form 10-K for the fiscal
         year ended September 30, 1996, is incorporated herein by reference.

         Amendment Agreement No. 1 to Fourth Amended and Restated Revolving
         Credit and Reimbursement Agreement, made as of September 30, 1996,
         previously filed and included as Exhibit 4.1 to the Company's Quarterly
         Report on Form 10-Q for the quarter ended March 31, 1997, is
         incorporated herein by reference.

(10)     Material contracts

         Not applicable


                                                       

                                       13
<PAGE>
 
                          INDEX TO EXHIBITS (Continued)



(11)     Statement re computation of per share earnings.

         Not applicable

(15)     Letter re unaudited interim financial information.

         Not applicable.

(18)     Letter re change in accounting principles.

         Not applicable.

(19)     Report furnished to security holders.

         Not applicable.

(22)     Published report regarding matters submitted to vote of security 
         holders.

         Not applicable

(23)     Consents of experts and counsel.

         Not applicable.

(24)     Power of attorney.

         Not applicable.

(27)     Financial Data Schedule.

         Financial Data Schedule is included herein as Exhibit 27.1 at page 
         15 of this report.

(99)     Additional exhibits.

         Not applicable.

                                       14

<TABLE> <S> <C>

<PAGE>


<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
FINANCIAL STATEMENTS INCLUDED WITHIN THE COMPANY'S DECEMBER 31, 1998 FORM
10-Q AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL
STATEMENTS.
</LEGEND>
<MULTIPLIER> 1,000
       
<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          SEP-30-1999
<PERIOD-START>                             OCT-01-1998
<PERIOD-END>                               DEC-31-1998
<CASH>                                           8,574
<SECURITIES>                                         0
<RECEIVABLES>                                  320,637
<ALLOWANCES>                                    67,355
<INVENTORY>                                     25,086
<CURRENT-ASSETS>                               317,582
<PP&E>                                         980,544
<DEPRECIATION>                                 201,428
<TOTAL-ASSETS>                               1,161,400
<CURRENT-LIABILITIES>                          143,172
<BONDS>                                              0
                                0
                                          0
<COMMON>                                         2,519
<OTHER-SE>                                     820,670
<TOTAL-LIABILITY-AND-EQUITY>                 1,161,400
<SALES>                                              0
<TOTAL-REVENUES>                               305,496
<CGS>                                                0
<TOTAL-COSTS>                                  202,004
<OTHER-EXPENSES>                                22,084
<LOSS-PROVISION>                                29,095
<INTEREST-EXPENSE>                               1,360
<INCOME-PRETAX>                                 50,953
<INCOME-TAX>                                    19,998
<INCOME-CONTINUING>                             30,955
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                    30,955
<EPS-PRIMARY>                                      .12
<EPS-DILUTED>                                      .12
        

</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission